Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Severine Vermeire, Gert Van Assche & Paul Rutgeerts. (2007) Role of biomarkers in the diagnosis of inflammatory bowel disease. Expert Opinion on Medical Diagnostics 1:4, pages 481-488.
Read now
Read now
J. Kjeldsen, K. Lauritsen, O. B. Schaffalitzky & De Muckadell. (1997) Serum Concentrations of Orosomucoid: Improved Decision-Making for Tapering Prednisolone Therapy in Patients with Active Inflammatory Bowel Disease?. Scandinavian Journal of Gastroenterology 32:9, pages 933-941.
Read now
Read now
J. Kjeldsen. (1993) Treatment of Ulcerative Colitis with High Doses of Oral Prednisolone : The Rate of Remission, the Need for Surgery, and the Effect of Prolonging the Treatment. Scandinavian Journal of Gastroenterology 28:9, pages 821-826.
Read now
Read now
J. Kjeldsen & O. B. Schaffalitzky De Muckadell. (1993) Assessment of Disease Severity and Activity in Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 28:1, pages 1-9.
Read now
Read now
V. A. Danis, A. D. Harries & R. V. Heatley. (1984) Antigen—Antibody Complexes in Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 19:5, pages 603-606.
Read now
Read now
S. H. Saverymuttu, A. M. Peters, H. J. F. Hodgson & V. S. Chadwick. (1983) Assessment of Disease Activity in Ulcerative Colitis Using Indium-111-Labelled Leukocyte Faecal Excretion. Scandinavian Journal of Gastroenterology 18:7, pages 907-912.
Read now
Read now
A. Krook, G. Järnerot & D. Danielsson. (1981) Clinical Effect of Metronidazole and Sulfasalazine on Crohn's Disease in Relation to Changes in the Fecal Flora. Scandinavian Journal of Gastroenterology 16:4, pages 569-575.
Read now
Read now
Henrik Nielsen, Per Hyltoft Petersen, Ulla Feldt-Rasmussen & Vibeke Binder. (1979) Variations in Plasma Protein Concentrations in Individuals with Ulcerative Colitis: Analytical and Biological Factors. Scandinavian Journal of Clinical and Laboratory Investigation 39:6, pages 495-502.
Read now
Read now
Christen Axelsson & Stig Jarnum. (1977) Assessment of the Therapeutic Value of an Elemental Diet in Chronic Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 12:1, pages 89-96.
Read now
Read now
Kristina Lenz. (1976) Bile Acid Metabolism and Vitamin B12 Absorption in Ulcerative Colitis. Scandinavian Journal of Gastroenterology 11:8, pages 769-775.
Read now
Read now
Kristina Lenz, K. Birger Jensen & S. Jarnum. (1976) Bile Acid Metabolism and Plasma Protein Turnover in Crohn’s Disease. Scandinavian Journal of Gastroenterology 11:7, pages 721-727.
Read now
Read now
Articles from other publishers (41)
Barbara Lisowska-Myjak, Hanna Zborowska, Radosław Jaźwiec, Maria Karlińska & Ewa Skarżyńska. (2021) Serum indoxyl sulphate and its relation to albumin and α1-acid glycoprotein as a potential biomarkers of maternal intestinal metabolism during pregnancy and postpartum. PLOS ONE 16:11, pages e0259501.
Crossref
Crossref
Masaaki Higashiyama, Shunsuke Komoto, Yasuo Suzuki, Mamoru Watanabe, Toshifumi Hibi, Soichiro Miura & Ryota Hokari. (2020) Relation of geriatric nutritional risk index with clinical risks in elderly‐onset ulcerative colitis. Journal of Gastroenterology and Hepatology 36:1, pages 163-170.
Crossref
Crossref
Bhargava K Reddy, Dursun Delen & Rupesh K Agrawal. (2018) Predicting and explaining inflammation in Crohn’s disease patients using predictive analytics methods and electronic medical record data. Health Informatics Journal 25:4, pages 1201-1218.
Crossref
Crossref
Mayu Uchihara, Jun Kato, Saya Tsuda, Takeichi Yoshida, Takao Maekita, Mikitaka Iguchi & Masayuki Kitano. (2017) Blood biomarkers reflect integration of severity and extent of endoscopic inflammation in ulcerative colitis. JGH Open 1:3, pages 98-104.
Crossref
Crossref
Abhik Bhattacharya, Bhavana B. Rao, Ioannis E. Koutroubakis, Benjamin Click, Eric J. Vargas, Miguel Regueiro, Marc Schwartz, Jason M. Swoger, Dmitriy Babichenko, Douglas Hartmann, Claudia R. Rivers, Arthur BarrieIIIIII, Jana G. Hashash, Michael A. Dunn & David G. Binion. (2016) Silent Crohnʼs Disease Predicts Increased Bowel Damage During Multiyear Follow-up. Inflammatory Bowel Diseases 22:11, pages 2665-2671.
Crossref
Crossref
Pablo Miranda-García, María Chaparro & Javier P. Gisbert. (2016) Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease. Gastroenterología y Hepatología 39:8, pages 508-515.
Crossref
Crossref
Pablo Miranda-García, María Chaparro & Javier P. Gisbert. (2016) Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease. Gastroenterología y Hepatología (English Edition) 39:8, pages 508-515.
Crossref
Crossref
Tolga Han Efe, Tolga Cimen, Ahmet Goktug Ertem, Yusuf Coskun, Murat Bilgin, Haluk Furkan Sahan, Hilal Erken Pamukcu, Cagri Yayla, Hamza Sunman, Ilhami Yuksel & Ekrem Yeter. (2016) Atrial Electromechanical Properties in Inflammatory Bowel Disease. Echocardiography 33:9, pages 1309-1316.
Crossref
Crossref
Maria CappelloGaetano Cristian Morreale. (2016) The Role of Laboratory Tests in Crohn's Disease. Clinical Medicine Insights: Gastroenterology 9, pages CGast.S38203.
Crossref
Crossref
Gaetano C. Morreale, Maria Cappello & Antonio Craxì. 2016. Crohn’s Disease. Crohn’s Disease
15
30
.
Anna Vaiopoulou, Maria Gazouli, George Theodoropoulos & George Zografos. (2012) Current Advantages in the Application of Proteomics in Inflammatory Bowel Disease. Digestive Diseases and Sciences 57:11, pages 2755-2764.
Crossref
Crossref
Imerio Angriman, Marco Scarpa, Renata D'Incà, Daniela Basso, Cesare Ruffolo, Lino Polese, Giacomo C. Sturniolo, Davide F. D'Amico & Mario Plebani. (2007) Enzymes in feces: Useful markers of chronic inflammatory bowel disease. Clinica Chimica Acta 381:1, pages 63-68.
Crossref
Crossref
Javier P. Gisbert, Yago González-Lama & José Maté. (2007) Papel de los marcadores biológicos en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 30:3, pages 117-129.
Crossref
Crossref
D. DESAI, W. A. FAUBION & W. J. SANDBORN. (2007) Review article: biological activity markers in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 25:3, pages 247-255.
Crossref
Crossref
Lone G. M. Jørgensen, Lisbeth Fredholm, Per Hyltoft Petersen, Henrik Hey, Pia Munkholm & Ivan Brandslund. (2005) How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?. Clinical Chemistry and Laboratory Medicine (CCLM) 43:4.
Crossref
Crossref
Albert E. Jergens, C. Alan Schreiner, Dagmar E. Frank, Yosiya Niyo, Franklin E. Ahrens, P.D. Eckersall, Tammy J. Benson & Richard Evans. (2008) A Scoring Index for Disease Activity in Canine Inflammatory Bowel Disease. Journal of Veterinary Internal Medicine 17:3, pages 291-297.
Crossref
Crossref
A. Poullis, R. Foster, T. C. Northfield & M. A. Mendall. (2002) Faecal markers in the assessment of activity in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 16:4, pages 675-681.
Crossref
Crossref
Ole H Nielsen, Ben Vainer, Søren M Madsen, Jacob B Seidelin & Niels H H Heegaard. (2000) Clinical Reviews. American Journal of Gastroenterology 95:2, pages 359-367.
Crossref
Crossref
Ole Haagen Nielsen, Paolo Gionchetti, Mark Ainsworth, Ben Vainer, Massimo Campieri, Niels Borregaard & Lars Kjeldsen. (1999) Rectal Dialysate and Fecal Concentrations of Neutrophil Gelatinase-Associated Lipocalin, Interleukin-8, and Tumor Necrosis Factor-α in Ulcerative Colitis. American Journal of Gastroenterology 94:10, pages 2923-2928.
Crossref
Crossref
Keith Leiper, Ian J. London & Jonathan M. Rhodes. (1997) 9 Management of the first presentation of severe acute colitis. Baillière's Clinical Gastroenterology 11:1, pages 129-151.
Crossref
Crossref
Chang Gao, Pei-Yuan Xie & Yu-Guang Dai. (1996) Effect of the detoxifying and myogenic herb enema in treating 19 patients with ulcerative colitis. Chinese Journal of Integrated Traditional and Western Medicine 2:4, pages 281-284.
Crossref
Crossref
Humphrey J. F. Hodgson & Mansoor Bhatti. (1995) Assessment of Disease Activity in Ulcerative Colitis and Crohnʼs Disease. Inflammatory Bowel Diseases 1:2, pages 117-134.
Crossref
Crossref
Chintamaneni P. Choudari, Seamus O'Mahony, Gordon Brydon, Obedy Mwantembe & Anne Ferguson. (1993) Gut lavage fluid protein concentrations: Objective measures of disease activity in inflammatory bowel disease. Gastroenterology 104:4, pages 1064-1071.
Crossref
Crossref
H. J. F. HODGSON & M. Z. MAZLAM. (2007) Review article: assessment of drug therapy in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 5:6, pages 555-584.
Crossref
Crossref
HANS D. OCHS, SUSANNA H. FISCHER, DENNIS L. CHRISTIE, RODGER C. HAGGITT & DOUGLAS S. LEVINE. 1991. Immunotherapy with Intravenous Immunoglobulins. Immunotherapy with Intravenous Immunoglobulins
359
376
.
J. Graham Watson & A. Graham Bird. 1990. Handbook of Immunological Investigations in Children. Handbook of Immunological Investigations in Children
75
87
.
MICHAEL CAMILLERI & MARITZA PROANO. (1989) Advances in the Assessment of Disease Activity in Inflammatory Bowel Disease. Mayo Clinic Proceedings 64:7, pages 800-807.
Crossref
Crossref
I. T. Beck. (1987) Laboratory assessment of inflammatory bowel disease. Digestive Diseases and Sciences 32:S12, pages S26-S41.
Crossref
Crossref
R. E. CHAMBERS, P. STROSS, R. E. BARRY & J. T. WHICHER. (2008) Serum amyloid A protein compared with C‐reactive protein, alpha 1‐antichymotrypsin and alpha 1‐acid glycoprotein as a monitor of inflammatory bowel disease. European Journal of Clinical Investigation 17:5, pages 460-467.
Crossref
Crossref
M. Vrethem, S. Öhrnan, H. Schenck, P. Forsberg & J.-E. Olsson. (1987) Comparison of concentration of orosomucoid in serum and cerebrospinal fluid in different neurological diseases. Acta Neurologica Scandinavica 75:5, pages 328-331.
Crossref
Crossref
John W. Singleton. 1986. Inflammatory Bowel Diseases 1986. Inflammatory Bowel Diseases 1986
115
124
.
B. Shine, Louise Berghouse, J.E.Lennard Jones & J. Landon. (1985) C-Reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Clinica Chimica Acta 148:2, pages 105-109.
Crossref
Crossref
N. S. Ambrose, R. N. Allan, M. R. B. Keighley, D. W. Burdon, Denise Youngs, P. Barnes & J. E. Lennard-Jones. (1985) Antibiotic therapy for treatment in relapse of intestinal Crohn's disease. Diseases of the Colon & Rectum 28:2, pages 81-85.
Crossref
Crossref
Rebecca L. Milsap, Donald E. George, Stanley J. Szefler, Kathleen A. Murray, Emanuel Lebenthal & William J. Jusko. (1983) Effect of inflammatory bowel disease on absorption and disposition of prednisolone. Digestive Diseases and Sciences 28:2, pages 161-168.
Crossref
Crossref
Bo Ursing, Thor Alm, Franz Bárány, Ingemar Bergelin, Karin Ganrot-Norlin, Jürgen Hoevels, Bernhard Huitfeldt, Gunnar Jarnerot, Urban Krause, Aud Krook, Björn Lindström, Örjan Nordle & Anders Rosén. (1982) A Comparative Study of Metronidazole and Sulfasalazine for Active Crohn's Disease: The Cooperative Crohn's Disease Study in Sweden. Gastroenterology 83:3, pages 550-562.
Crossref
Crossref
Anders Rosén, Bo Ursing, Thor Alm, Franz Bárány, Ingemar Bergelin, Karin Ganrot-Norlin, Jürgen Hoevels, Bernhard Huitfeldt, Gunnar Järnerot, Urban Krause, Aud Krook, Björn Lindström & Örjan Nordle. (1982) A Comparative Study of Metronidazole and Sulfasalazine for Active Crohn's Disease: The Cooperative Crohn's Disease Study in Sweden. Gastroenterology 83:3, pages 541-549.
Crossref
Crossref
E. A. FAGAN, R. F. DYCK, P. N. MATON, H. J. F. HODGSON, V. S. CHADWICK, AVIVA PETRIE & M. B. PEPYS. (2008) Serum levels of C‐reactive protein in Crohn's disease and ulcerative colitis. European Journal of Clinical Investigation 12:4, pages 351-359.
Crossref
Crossref
HJ Hodgson. (2012) Assessment of drug therapy in inflammatory bowel disease.. British Journal of Clinical Pharmacology 14:2, pages 159-170.
Crossref
Crossref
Joseph B. Kirsner & Roy G. Shorter. (1982) Recent Developments in Nonspecific Inflammatory Bowel Disease. New England Journal of Medicine 306:13, pages 775-785.
Crossref
Crossref
W T Cooke. (2018) Factors in the Management of Crohn's Disease: A Discussion Paper. Journal of the Royal Society of Medicine 74:10, pages 753-758.
Crossref
Crossref
N A Buckell, J E Lennard-Jones, M A Hernandez, J Kohn, P G Riches & J Wadsworth. (1979) Measurement of serum proteins during attacks of ulcerative colitis as a guide to patient management.. Gut 20:1, pages 22-27.
Crossref
Crossref